Eckert & Ziegler Strahlen- und Medizinte operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eckert & Ziegler Strahlen- und Medizinte with three other
pharmaceutical manufacturers in Europe:
Alkaloid AD Skopje
sales of 8.29 billion Denar [US$150.43 million]
Dottikon ES Holding AG
(121.43 million Swiss Francs [US$124.80 million]
of which 90%
was Pharma Products), and
Laboratorio Reig Jofre SA
based in Spain
(161.13 million Euro [US$180.04 million]
of which 87%
was Sale of Pharmaceutical Products).
Eckert & Ziegler Strahlen- und Medizinte reported sales of 137.94 million Euro (US$154.12 million)
December of 2016.
decrease of 1.5%
versus 2015, when the company's sales were 140.05 million Euro.
Contributing to the drop in overall sales was the 99.8% decline
in Others, from 7.99 million Euro to 16,000.00 Euro.
There were also decreases in sales in
Radiation Therapy (down 19.9% to 24.78 million Euro)
However, these declines were partially offset by the increase in sales of
Isotope Products (up 9.6% to 73.33 million Euro)
Radiation Pharma (up 16.3% to 39.81 million Euro)